Clinical Cancer Drugs

Editor-in-Chief

Giulio Francia
Department of Biological Sciences
The University of Texas
El Paso, TX
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor

Articles Ahead of Print

Inhibition of ERN1 Signaling is Important for the Suppression of Tumor Growth

Oleksandr H. Minchenko*, Dariia O. Tsymbal, Olena O. Khita and Dmytro O. Minchenko

Effect of Ginger Extract on 4T1 Breast Cancer Cell Line in Balb/c Mouse

Alireza Pooyae Golizadeh, Asa Ebrahimi*, Mahdi Rahaie and Farzaneh Samiee

In Silico Based Approach to Investigate Plant Lignans as Inhibitor Candidates for Estrogen Receptor in Breast Cancer

Farzaneh Mohamadyar-Toupkanlou*, Mina Esfandiari, Mahshid Sadat Kashef-Saberi, Mahboubeh Kabiri and Zahra Bazi

COVID-19 Related Publications Focusing on Cancer: Systematic Review of a Delicate Balance

Mahdi F. Naimi, Maira Khan, Mary Mahler and Urban Emmenegger*

The Antimalarial Drug Pyronaridine Inhibits Topoisomerase II in Breast Cancer Cells and Hinders Tumor Progression In Vivo

Paulina J. Villanueva, Denisse A Gutierrez, Lisett Contreras, Karla Parra, Aldo Segura-Cabrera, Armando Varela-Ramirez and Renato J Aguilera*

Combining Chemotherapy with Immunotherapy in Colorectal Cancer: A Review

John Thomas Palathingal*, Basil Sunny and Vismaya Vijayan

Withdrawn: Intraoperative Sono-photodynamic Therapy for Anaplastic Astrocytoma Grade III With Transformation in Glioblastoma Grade IV

Dmitry Tzerkovsky*, Fedor Borichevsky, Yuri Grachev and Yuri Istomin